Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Key Ratios

Key Ratios

Price & Volume

Recent Price $16.05
52 Week High $20.55
52 Week Low $10.20
Volume (10 Day Average) (Mil) $0.22
Beta $0.49

Dividends

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Current Ratio (MRQ) $5.38
LT Debt to Equity (MRQ) (%) --
Total Debt to Equity (MRQ) (%) --

Valuation

P/E (TTM) --
Price to Revenue (TTM) $621.90
Price to Cash Flow (TTM) --
Price to Book (MRQ) $6.10

Per Share

Revenue/Share (TTM) $0.03
EPS Fully Diluted (MRQ) $-0.66
Book Value/Share (MRQ) $2.63
Cash Flow/Share (TTM) $-2.93
Cash (MRQ) $3.11

Management Effectiveness

Return on Equity (TTM) (%) -93.16
Return on Assets (TTM) (%) -77.60
Return on Investment (TTM) (%) -93.06

Profitability

Operating Margin (TTM) (%) -9,527.49
Net Profit Margin (TTM) (%) -9,400.91
Gross Margin (TTM) (%) --


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved